Literature DB >> 11869010

Extracellular matrix proteins and chemoradiotherapy: alpha5beta1 integrin as a predictive marker in rectal cancer.

D G Jayne1, R M Heath, O Dewhurst, N Scott, P J Guillou.   

Abstract

AIMS: To investigate the effects of extracellular matrix (ECM) protein expression on the rates of apoptosis and proliferation in rectal cancers and subsequent response to chemoradiotherapy (CRT).
METHODS: The expression of fibronectin, collagen IV, laminin and the fibronectin receptor (FnR, alpha5beta1 integrin) were analysed in 32 pre-treatment rectal cancer biopsies by immunohistochemistry. ECM expression was correlated with tumour mitotic index (MI), apoptotic index (AI) and histopathological response to CRT.
RESULTS: 18/32 cancers showed a poor response and 14/32 a good response (5/14 with complete pathological response) to CRT. Moderate to strong staining was seen in 22/32 cancers for fibronectin, 5/32 for collagen IV and 18/32 for laminin. Tumour FnR was related to stromal fibronectin content, and was significantly associated with CRT response; good responders having higher FnR expression compared to poor responders. No association was found between FnR expression and either MI or AI in pre-treatment biopsies, nor between MI or AI and CRT response.
CONCLUSIONS: Tumour FnR expression is independent of MI and AI, and may serve as a useful marker for CRT response in rectal cancer. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869010     DOI: 10.1053/ejso.2001.1182

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Tumor vascular microenvironment determines responsiveness to photodynamic therapy.

Authors:  Amanda L Maas; Shirron L Carter; E Paul Wileyto; Joann Miller; Min Yuan; Guoqiang Yu; Amy C Durham; Theresa M Busch
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

2.  Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

Authors:  Ashish Garg; Alison W Tisdale; Eman Haidari; Efrosini Kokkoli
Journal:  Int J Pharm       Date:  2008-09-19       Impact factor: 5.875

3.  The Promise of Integrins as Effective Targets for Anticancer Agents.

Authors:  William L. Rust; Stephen W. Carper; George E. Plopper
Journal:  J Biomed Biotechnol       Date:  2002

Review 4.  Tumor Targeting via Integrin Ligands.

Authors:  Udaya Kiran Marelli; Florian Rechenmacher; Tariq Rashad Ali Sobahi; Carlos Mas-Moruno; Horst Kessler
Journal:  Front Oncol       Date:  2013-08-30       Impact factor: 6.244

Review 5.  Colorectal cancer and basement membranes: clinicopathological correlations.

Authors:  Charalampos C Mylonas; Andreas C Lazaris
Journal:  Gastroenterol Res Pract       Date:  2014-12-28       Impact factor: 2.260

6.  17β-Estradiol Protects Rat Annulus Fibrosus Cells Against Apoptosis via α1 Integrin-Mediated Adhesion to Type I Collagen: An In-vitro Study.

Authors:  Chun-Ming Zhao; Qian Chen; Wen-Jie Zhang; Ai-Bing Huang; Wei Zhang; Hui-Lin Yang; Zhi-Ming Zhang
Journal:  Med Sci Monit       Date:  2016-04-24

Review 7.  Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.

Authors:  Moying Li; Qiyun Xiao; Nachiyappan Venkatachalam; Ralf-Dieter Hofheinz; Marlon R Veldwijk; Carsten Herskind; Matthias P Ebert; Tianzuo Zhan
Journal:  Ther Adv Med Oncol       Date:  2022-02-21       Impact factor: 8.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.